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the Extracellular Matrix edited by David A Cheresh 
and Robert P Mecham. Academic Press, 1994, 278 
pages. $89.95 hardcover (ISBN O-12-171160-9). 
If, like me, you are new to the field of integrin biology, 
you may have been looking for a slim volume that covers 
most of the main topics of this rapidly expanding field; 
this may be the book for you.This vade-mecum describes 
in depth most of the important aspects of integrin struc- 
ture, function and biology, a field that has attracted scien- 
tists engaged in basic, applied and clinical aspects of 
medical research. Each chapter is a stand-alone review 
written by experts in the field, and is fully referenced 
with titles. A textbook of current research is, of course, 
an oxymoron, and this book covers the field until the 
end of 1993. The organization is such that many topics 
get touched on more than once, and I found the multi- 
ple points of view very useful. 
Integrins are heterodimeric proteins that span the plasma 
membrane; they have a large extracellular portion, a 
transmembrane helix and a short but very important 
cytoplasmic tail. They promote both cell-cell and 
cell-matrix interactions, and while their extracellular 
domains are sticking to other proteins, their cytoplasmic 
tails are doing all sorts of interesting things, including 
reorganizing the cytoskeleton. Sometimes the tails can 
trigger the activation of the binding domains (inside-out 
signaling). On the other hand, sometimes it is binding to 
the outside that triggers intracellular signal transduction 
pathways (outside-in signaling). If integrins represent a 
connection between the extracellular environment and 
the intracellular compartment, then the corollary is that 
whenever the environment of a cell influences its activity 
(i.e. most of the time) integrins have an obligatory and 
maybe essential role.This means that they are going to be 
implicated in the whole gamut of cell biology and 
disease; they are important in cell differentiation, prolifer- 
ation and migration, so they are involved in embryogen- 
esis, wound healing, inflammation, cancer, and so on. 
There are so far 21 members of the integrin family, 
defined by the pairing of distinct OL and B subunits, 
expressed on different cell types with very different or 
sometimes very similar specificities. With a family of this 
size, one feels it should one day be possible to know 
them all on a first-name basis. In the meantime this book 
has a very handy index so you need not worry about 
confusing 06B4 and ovB6 ever again. 
The book kicks off with a stimulating chapter on the 
structural basis of integrin-ligand interactions, providing 
a nice introduction and background to the rest of the 
book. Of course there was no three-dimensional infor- 
mation available on integrins when this chapter was 
written, so some of the speculation is rather fanciful. The 
importance of the I domain in ligand binding had not 
been demonstrated when Chapter 1 was written, but 
luckily by the time we get to Chapter 7, the role of the I 
domain has been established. The author makes one 
mistake in proposing that Asp is preferred to Glu because 
Asp is longer than Glu; Asp is shorter. 
The next four chapters discuss the big topics. Covered 
first is the role of integrins in signaling. This chapter is 
necessarily short, because although integrins are unam- 
biguously involved in a variety of signal transduction 
pathways, the field is still at the stage of ‘what gets phos- 
phorylated when and where’, without being able to dis- 
tinguish between deliberate targets and innocent 
bystanders. It is also short so as not to preempt the next 
chapter on interactions with the cytoskeleton. The 
chapter is long enough, however, to make clear how fas- 
cinating it is that these short and innocuous-looking 
cytoplasmic domains can do so much, and raise the 
question of how does transmembrane signaling work? 
Chapter 3 reviews the expanding database on focal 
adhesion: again, lots of interesting data, lots of unan- 
swered questions. Next comes a chapter on interactions 
with the extracellular matrix, presenting evidence for 
the involvement of integrins in both the induction and 
the recognition of changes in the composition of the 
extracellular matrix. These intersecting events presum- 
ably regulate morphogenesis, differentiation, tissue 
regeneration, and, in pathogenic situations, tumor 
growth and metastasis. Chapter 5 has one of those 
apparently profound titles: ‘lntegrins in development’. 
0 Current Biology Ltd ISSN 1074-5521 515 
516 Chemistry & Biology 1995, Vol 2 No 8 
But, as the authors note, most of the studies focus on the 
question of when and where integrins appear during 
development; no big answers here yet. Still, the chapter 
provides a useful compendium of data. 
Chapters 6-8 focus on particular cell types and/or par- 
ticular integrins. We get a rather personal account of 
epithelial cell integrins, focussing on the somewhat 
obscure c@p4, and this is followed by a well written and 
comprehensive account of the more familiar leukocyte 
integrins, and the dynamic regulation of integrin adhe- 
siveness in trafficking. Next, there is a very complete 
account of the doyen of the integrin class, cxnbP3 (the 
‘platelet integrin’). 
Finally, there is a discussion of the therapeutic potential 
of integrin antagonists. These have applications in the 
treatment of thrombosis, inflammation, tissue remodeling 
and cancer. The focus is on drug design to treat osteo- 
porosis and thrombosis, but the chapter illustrates general 
principles that may be applicable to other diseases. 
In conclusion, a handy volume that makes good bed- 
time reading; light in weight, but not a lightweight. 
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